SUVRETTA CAPITAL MANAGEMENT, LLC
Top Portfolio Positions
88 positions ·
$3,883,029,505 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
12,327,000 | $290,424,120 | 7.48% | |
| MANE |
Veradermics, Inc
Healthcare
|
4,168,970 | $263,270,455 | 6.78% | |
| SPY |
Spdr S&P 500 ETF Trust
|
350,000 | $227,619,000 | 5.86% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
1,153,496 | $143,783,276 | 3.70% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
3,518,471 | $141,548,088 | 3.65% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
7,581,029 | $137,140,814 | 3.53% | |
| BNTC |
Benitec Biopharma Inc.
Healthcare
|
11,548,351 | $122,989,938 | 3.17% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
3,818,600 | $116,085,440 | 2.99% | |
| IMTX |
Immatics N.V.
Healthcare
|
11,190,129 | $110,110,869 | 2.84% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
5,030,993 | $108,669,448 | 2.80% |
Portfolio Trend
25 quarters · across all stocks
Holdings in ABEO
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,988,480 | 2,676,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,102,520 | 2,676,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,129,280 | 2,676,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,199,680 | 2,676,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,542,994 | 3,685,503 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,528,251 | 3,685,503 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,292,378 | 3,685,503 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,626,532 | 3,685,503 | Shares | Sole | 2024-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||